Tirzepatide is an imbalanced and biased dual gip and glp-1 receptor agonist
Methods Data source and cohort This retrospective cohort study drew on data from the TriNetX Global Collaborative Network, a real-time clinical research platform that aggregates de-identified electronic medical records from more than 135 health-care organizations (HCOs) across the Americas, Europe-Middle East-Africa, and Asia-Pacific regions, encompassing over 130 million patient records
Teneligliptin, a DPP-4 inhibitor, demonstrated mild antinociceptive effects against heat-induced acute pain, but remarkable analgesic effects against partial sciatic nerve transection (PSNT)-induced neuropathic pain in rats [70]
Skin Therapy Lett
Early-phase clinical trial data, including results from a Phase 2 trial published in the New England Journal of Medicine in 2023, demonstrated mean weight loss of up to approximately 24% of baseline body weight at 48 weeks in adults with obesity who did not have type 2 diabetes
Wang et al., Gut microbiota-tryptophan metabolism-GLP-1 axis participates in -cell regeneration induced by dapagliflozin